Description: SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety. It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products; and cannabis products for recreational use under the Hempamed, Princess Stardust, The Hempany, and Hempamed Rx brand names. The company was formerly known as Ledgertech SE and changed its name to SynBiotic SE. SynBiotic SE was founded in 2015 and is based in Munich, Germany.
Home Page: www.synbiotic.com
Barer Strasse 7
Munich,
80333
Germany
Phone:
49 89 6003 7544
Officers
Name | Title |
---|---|
Mr. Daniel Kruse | Managing Director |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 277.7778 |
---|---|
Trailing PE: | 0 |
Price-to-Book MRQ: | 1.9717 |
Price-to-Sales TTM: | 8.1498 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 55 |